Pilgrim raises $25M to develop airborne biological threat detection

CDC: The Centers for Disease Control and Prevention is the U.S. public health agency responsible for protecting against infectious disease threats. It partners with innovative companies on detection and response technologies for biological hazards. The agency is working with Pilgrim on systems to identify threats like Ebola and anthrax. Pilgrim: Pilgrim is a startup building sensor and genomic-sequencing technology to detect airborne biological threats. It has developed the Argus system and is collaborating with public health authorities on biodefense applications. The company recently received investment from Anthropic executives as awareness grows around AI-related biological risks. Anthropic: Anthropic develops frontier AI models with a strong emphasis on safety and alignment research. Its Claude models power a range of applications while incorporating safeguards against misuse. Leaders from the company have invested in Pilgrim amid heightened industry focus on biological security risks following Anthropic's recent threat intelligence report. AI Biosecurity Risks: Anthropic's September 2026 threat report detailed multiple cases where its models were used in ways that could support biological weapons development, underscoring the need for new detection technologies. Industry Collaboration: AI companies and biosecurity startups are increasingly teaming up with government health agencies to develop tools that counter potential misuse of advanced AI in life sciences.